CHRS

Latest SEC Filings & News for CHRS

2 most recent filings and news items mentioning CHRS. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day

curl "https://api.brieftape.com/v1/tickers/CHRS/news?limit=20"

Pull CHRS filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day

EarningsAug 5, 2026Neutral

Coherus CSV revenue up 15% as pipeline studies advance

Coherus reports LOQTORZI revenue of $13.6 million for Q2 2026. Clinical data continues to mature across programs, with preliminary evidence of activity featuring a new cancer asset.

View filing at SEC.gov →

LeadershipJun 15, 2026Neutral

Coherus Oncology auditor Ernst & Young agrees with Item 4.01 disclosure

Ernst & Young LLP confirmed agreement with statements in Coherus Oncology's Form 8-K Item 4.01 filing dated June 12, 2026, regarding an auditor change. The filing indicates a transition in the company's external audit relationship.

View filing at SEC.gov →

AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.